Fractionated palliative thoracic radiotherapy in non-small cell lung cancer – futile or worth-while?

BACKGROUND: Palliative thoracic radiotherapy (PTR) can relieve symptoms originating from intra-thoracic disease. The optimal timing and fractionation of PTR is unknown. Time to effect is 2 months. The primary aim of this retrospective study was to investigate survival after PTR, hypothesizing that a...

Descripción completa

Detalles Bibliográficos
Autores principales: Støchkel Frank, Malene, Schou Nørøxe, Dorte, Nygård, Lotte, Fredberg Persson, Gitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756366/
https://www.ncbi.nlm.nih.gov/pubmed/29304789
http://dx.doi.org/10.1186/s12904-017-0270-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756366/
https://www.ncbi.nlm.nih.gov/pubmed/29304789
http://dx.doi.org/10.1186/s12904-017-0270-4

Ejemplares similares